Hodgkins_Lymphoma_Flashcards
What is the standard combination chemotherapy regimen for Hodgkin’s Lymphoma?
The standard combination chemotherapy regimen for Hodgkin’s Lymphoma is ABVD: Adriamycin (Doxorubicin), bleomycin, vinblastine, and dacarbazine, with or without radiotherapy.
What is the treatment for favourable Hodgkin’s Lymphoma?
The treatment for favourable Hodgkin’s Lymphoma is two cycles of ABVD followed by low dose radiation.
What are the treatment options for unfavourable Hodgkin’s Lymphoma?
The treatment options for unfavourable Hodgkin’s Lymphoma are four cycles of ABVD followed by medium radiation, or BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisolone), followed by two cycles of ABVD and radiotherapy.
What is the treatment approach for primary refractory or relapse Hodgkin’s Lymphoma?
The treatment approach for primary refractory or relapse Hodgkin’s Lymphoma includes high-dose chemotherapy and autologous stem cell transplantation (ASCT).
What can be prescribed if autologous stem cell transplantation (ASCT) fails or is unsuitable in Hodgkin’s Lymphoma?
Brentuximab vedotin (anti CD30) can be prescribed if ASCT fails or is unsuitable in Hodgkin’s Lymphoma.
What are the last line treatments for Hodgkin’s Lymphoma?
The last line treatments for Hodgkin’s Lymphoma are Nivolumab and Pembrolizumab, which both block PD-1.
What imaging technique is used to monitor treatment response in Hodgkin’s Lymphoma?
PET scanning is used to monitor treatment response in Hodgkin’s Lymphoma.
What is the cure rate for Hodgkin’s Lymphoma?
The cure rate for Hodgkin’s Lymphoma is 80%.
